Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis

Human African trypanosomiasis (HAT, also called sleeping sickness), a neglected tropical disease endemic to sub-Saharan Africa, is caused by the parasites Trypanosoma brucei gambiense and T. brucei rhodesiense. Current drugs against this disease have significant limitations, including toxicity, incr...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Wenzler, Tanja, Yang, Sihyung, Braissant, Olivier, Boykin, David W., Brun, Reto, Wang, Michael Zhuo
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2013
נושאים:
Experimental Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811327/
https://ncbi.nlm.nih.gov/pubmed/23959303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00398-13
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים